Benefits of enzyme replacement therapy with Myozyme (alglucosidase alfa), anecdotally reported in late-onset Pompe disease, range from motor and pulmonary improvement in less severely affected patients, to stabilization with minimal improvement in those with advanced disease. We report a case of a 63-year-old patient with significant morbidity who made notable motor and pulmonary function gains after two years on therapy. Thus, improvements in those with advanced disease may be possible after long-term treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ymgme.2008.09.001 | DOI Listing |
Publication Analysis
Top Keywords
enzyme replacement
8
replacement therapy
8
late-onset pompe
8
pompe disease
8
motor pulmonary
8
advanced disease
8
improvement ongoing
4
ongoing enzyme
4
therapy advanced
4
advanced late-onset
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!